Market Capitalization of Symbiotec Pharmalab Ltd
From Blinkx's GPT
Key Highlights
- The Latest Trading Price of Symbiotec Pharmalab Ltd is ₹ 1095 as of 01 Sep 16:01 .
Symbiotec Pharmalab Ltd
NSE: SYMBIOTEC
Share Price
Market Price of Symbiotec Pharmalab Ltd
1M
1Y
3Y
5Y
SWOT Analysis Of Symbiotec Pharmalab Ltd
BlinkX Score for Symbiotec Pharmalab Ltd
Asset Value vs Market Value of Symbiotec Pharmalab Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Symbiotec Pharmalab Ltd
Historical P/E Ratio of Symbiotec Pharmalab Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Symbiotec Pharmalab Ltd
Historical Revenue of Symbiotec Pharmalab Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Symbiotec Pharmalab Ltd
Historical EBITDA of Symbiotec Pharmalab Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Symbiotec Pharmalab Ltd
Historical Net Profit of Symbiotec Pharmalab Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Symbiotec Pharmalab Ltd
Dividend Payout Over Time
About Symbiotec Pharmalab Ltd
- Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh.
- Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing.
- The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility.
- It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. The Company has a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients.
Symbiotec Pharmalab Ltd News Hub
Symbiotec Pharmalab IPO ends with 71.26 times subcription
The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,3
Read more
28 Aug 26
